Sean McCutcheon
Stock Analyst at Raymond James
(2.47)
# 2,242
Out of 5,152 analysts
12
Total ratings
33.33%
Success rate
9.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Initiates: Outperform | $24 | $9.97 | +140.72% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $99.64 | -23.73% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $9.10 | +31.87% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $13.97 | +365.28% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $5.53 | +62.75% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.05 | +436.59% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $8.71 | +164.06% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $11.16 | +258.42% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $62.19 | +12.56% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $17.75 | +384.51% | 1 | Mar 13, 2024 |
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $9.97
Upside: +140.72%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $99.64
Upside: -23.73%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $9.10
Upside: +31.87%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $13.97
Upside: +365.28%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $5.53
Upside: +62.75%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.05
Upside: +436.59%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $8.71
Upside: +164.06%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $11.16
Upside: +258.42%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $62.19
Upside: +12.56%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $17.75
Upside: +384.51%